Background And Aims: Plasma apolipoprotein M (APOM) is bound to HDL-particles and has anti-atherogenic effects. The present study explored whether plasma APOM is reduced in patients with chronic kidney disease (CKD), and associated with cardiovascular disease (CVD). In addition, we tested the hypothesis that the excretion of APOM into the urine is increased in patients with kidney disease.
Methods: Plasma samples were collected from a cohort of patients with CKD stages 1 to 5D (N = 409) and controls (N = 35). Urine was collected from 47 subjects. Plasma APOM was measured with sandwich ELISA and urine APOM with competitive ELISA.
Results: Plasma APOM levels were reduced in patients with CKD stages 3-5D as compared to patients with CKD stages 1 + 2 and controls (p < 0.01). CKD patients with known CVD displayed even further reduction in plasma APOM levels than CKD patients without known CVD (p < 0.001). Fast-phase liquid chromatography showed that plasma APOM was primarily associated with HDL-cholesterol (HDL-C) across CKD stages. Accordingly, when plasma APOM values were corrected for HDL-C, a significant difference only persisted between patients with CKD stage 3 and stages 1 + 2 (p < 0.05), and the difference between CKD patients with and without known CVD disappeared. Urine APOM/creatinine ratio was not significantly increased in patients with kidney disease.
Conclusions: The results show that the difference in plasma APOM levels observed between patients with mild and advanced CKD may mainly be due to differences in plasma HDL-C. Whether APOM plays a role in human uremic atherogenesis warrants further experimental studies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.815 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterisation of pregnancy-induced alterations in apolipoproteins and their associations with maternal metabolic risk factors and offspring birth outcomes: a preconception and longitudinal cohort study.
EBioMedicine
January 2025
Singapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore, Singapore; Department of Biochemistry and Precision Medicine Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Electronic address:
Background: Apolipoproteins as an integral part of lipoproteins are crucial for the transport and metabolism of lipids. However, there is a lack of longitudinal studies to quantify the concentrations of maternal apolipoproteins from preconception to postpartum and their associations with maternal metabolic health and offspring birth outcomes.
Methods: Quantification of apolipoproteins was performed on maternal plasma samples (N = 243 trios) collected at preconception, 26-28 weeks' pregnancy, and three months postpartum in the Singapore PREconception Study of long-Term maternal and child Outcomes (S-PRESTO) cohort study.
Insights into Medication-Induced Osteonecrosis of the Jaw Through the Application of Salivary Proteomics and Bioinformatics.
Int J Mol Sci
November 2024
Faculty of Medicine, University of P. J. Šafárik, 041 90 Košice, Slovakia.
Long-term treatment with bisphosphonates is accompanied by an increased risk of medication-related osteonecrosis of the jaw (MRONJ). Currently, no clinically useful biomarkers for the predictive diagnosis of MRONJ are available. To investigate the potential key proteins involved in the pathogenesis of MRONJ, a proteomic LC-MS/MS analysis of saliva was performed.
View Article and Find Full Text PDFIdentification of plasma proteins binding oxidized phospholipids using pull-down proteomics and OxLDL masking assay.
J Lipid Res
November 2024
Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria. Electronic address:
Article Synopsis
- Oxidized phospholipids (OxPLs) are recognized as harmful substances that promote inflammation, highlighting the need to understand how they can be detoxified by various plasma proteins.
- Researchers conducted pull-down-proteomic analysis to identify around 150 non-immunoglobulin proteins that specifically bind to oxidized phospholipids, particularly OxPAPC.
- The study confirmed that these proteins, alongside known oxidized phospholipid-binding proteins, can effectively mask OxPLs, potentially influencing their recognition by the immune system.
Effect of phospholipid transfer protein on plasma sphingosine-1-phosphate.
J Biol Chem
November 2024
Department of Cell Biology, SUNY Downstate Health Sciences University, Brooklyn, New York, USA; Molecular and Cellular Cardiology Program, VA New York Harbor Healthcare System, Brooklyn, New York, USA. Electronic address:
Article Synopsis
- Plasma phospholipid transfer protein (PLTP) is linked to cardiovascular diseases and is thought to influence levels of sphingosine-1-phosphate (S1P), a lipid mediator found in high-density lipoprotein (HDL).
- Research using knockout (KO) mice showed that both PLTP deficiency and double deficiency (with apoM) lead to a significant reduction in HDL and plasma S1P levels, with PLTP deficiency also lowering apoM levels.
- The study concluded that PLTP does not act as a direct carrier for S1P, but its depletion or overexpression affects S1P levels dramatically due to changes in HDL.
The adipocyte apolipoprotein M is negatively associated with inflammation.
J Lipid Res
October 2024
Institute of Metabolic and Cardiovascular Diseases (I2MC), Team MetaDiab, Institut National de la Santé et de la Recherche Médicale (Inserm), Université Toulouse III, Paul Sabatier (UPS), UMR1297, Toulouse, France. Electronic address:
Obesity is associated with the development of local adipose tissue (AT) and systemic inflammation. Most adipokines are upregulated with obesity and have pro-inflammatory properties. Few are downregulated and possess beneficial anti-inflammatory effects.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!